Effectiveness of a Multicomponent Group Psychological Intervention Program in Patients with Inflammatory Bowel Disease: A Randomized Trial.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
19 05 2021
Historique:
received: 08 04 2021
revised: 14 05 2021
accepted: 17 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 25 6 2021
Statut: epublish

Résumé

(1) Background: Stress, anxiety, and depression have been identified as factors that influence the development of inflammatory bowel disease (IBD). The main aim of this study was to test the effectiveness of group multicomponent cognitive-behavioral therapy at reducing stress, anxiety, and depression, and improving quality of life and the clinical course of the disease. (2) Methods: A total of 120 patients were evaluated using the General Perceived Stress Scale, Scale of Stress Perceived by the Disease, the anxiety and depression scale, and quality of life questionnaire for patients with IBD. Disease activity was measured using the Mayo Index for ulcerative colitis and CDAI for Crohn's disease, as well as the number of relapses self-reported by patients. Patients were randomized to receive group multicomponent cognitive-behavioral therapy or treatment as usual. (3) Results: The psychological intervention reduced stress (EAE: 45.7 ± 8.8 vs. 40.6 ± 8.4,

Identifiants

pubmed: 34069621
pii: ijerph18105439
doi: 10.3390/ijerph18105439
pmc: PMC8160847
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02614014']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Psychosom Res. 1967 Aug;11(2):213-8
pubmed: 6059863
Gastroenterology. 1976 Mar;70(3):439-44
pubmed: 1248701
BMC Gastroenterol. 2015 May 02;15:54
pubmed: 25934170
Inflamm Bowel Dis. 2021 Jan 04;:
pubmed: 33393632
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Clin Gastroenterol Hepatol. 2016 Jun;14(6):829-835.e1
pubmed: 26820402
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Scand J Gastroenterol. 2003 Jul;38(7):763-9
pubmed: 12889564
World J Gastroenterol. 2014 Apr 7;20(13):3663-71
pubmed: 24707152
Rev Esp Enferm Dig. 2007 Oct;99(10):593-8
pubmed: 18052663
Inflamm Bowel Dis. 2008 Dec;14(12):1660-6
pubmed: 18623174
Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006913
pubmed: 21328288
Clin Gastroenterol Hepatol. 2014 Aug;12(8):1246-56.e6
pubmed: 24534550
Cogn Behav Pract. 2010 Feb;17(1):102-113
pubmed: 23997572
Gastroenterology. 1989 Mar;96(3):804-10
pubmed: 2644154
Inflamm Bowel Dis. 2013 Nov;19(12):2704-15
pubmed: 23846488
Am J Gastroenterol. 2001 May;96(5):1470-9
pubmed: 11374685
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):189-199
pubmed: 28404134
Gastroenterol Hepatol. 2018 Feb;41(2):118-127
pubmed: 29275001
Inflamm Bowel Dis. 2009 Jul;15(7):1105-18
pubmed: 19161177
Inflamm Bowel Dis. 2012 Nov;18(11):2086-91
pubmed: 22294486
Inflamm Bowel Dis. 2006 Dec;12(12):1175-84
pubmed: 17119392
Clin Gastroenterol Hepatol. 2020 Aug;18(9):2019-2029.e11
pubmed: 31546058
Gen Hosp Psychiatry. 2004 Jan-Feb;26(1):50-8
pubmed: 14757303
Inflamm Bowel Dis. 2011 Sep;17(9):1863-73
pubmed: 21287660
Inflamm Bowel Dis. 2012 Dec;18(12):2301-9
pubmed: 22359369
Am J Gastroenterol. 2006 Apr;101(4):775-81
pubmed: 16494590
Inflamm Bowel Dis. 2016 Mar;22(3):694-701
pubmed: 26529560
Inflamm Bowel Dis. 2018 Oct 12;24(11):2303-2308
pubmed: 29788469
J Clin Psychol Med Settings. 2020 Sep;27(3):467-479
pubmed: 31025253
Gastroenterology. 2013 Jan;144(1):36-49
pubmed: 23063970
J Adv Nurs. 2002 Apr;38(2):152-60
pubmed: 11940128

Auteurs

Purificación Bernabeu (P)

Health Psychology Department, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, 03010 Alicante, Spain.

Carlos van-der Hofstadt (C)

Health Psychology Department, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, 03010 Alicante, Spain.

Jesús Rodríguez-Marín (J)

Departamento de Psicología de la Salud, Universidad Miguel Hernández, 03202 Elche, Spain.

Ana Gutierrez (A)

Servicio de Medicina Digestiva, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, 03010 Alicante, Spain.

Miguel Raúl Alonso (MR)

Health Psychology Department, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, 03010 Alicante, Spain.

Pedro Zapater (P)

Clinical Pharmachology Department, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, 03010 Alicante, Spain.

Rodrigo Jover (R)

Servicio de Medicina Digestiva, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, 03010 Alicante, Spain.

Laura Sempere (L)

Servicio de Medicina Digestiva, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria ISABIAL, 03010 Alicante, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH